Author: Riley Griffin Rising costs of prescription drugs have strained hospital budgets and operations, forcing health systems to cut costs by reducing staff, a new study found. Hospital drug spending increased by 18.5 percent between 2015 and 2017, a rate far exceeding medical inflation for the period, according to a report prepared for three health associations […]
Read MoreSun Pharma is voluntarily recalling 13,918 cartons of its vecuronium bromide injection, a muscle relaxer used as part of general anesthesia, in the U.S., according to The Hindu Business Line. The recall occured because particulate matter, later identified as glass, was found in the product. The affected lots include 10-milligram and 20-milligram strengths, distributed nationwide to […]
Read MoreBY ALEX KACIK BRKA dozen more health systems have joined the effort to produce a stable supply of generic drugs, Civica Rx announced Monday. Utah-based not-for-profit generic-drug company Civica Rx was spearheaded by Intermountain Healthcare, SSM Health, Trinity Health and Ascenion, which is no longer part of the endeavor. The venture represents the frustration of the numerous hospitals […]
Read MoreEarlier this week, a Food and Drug Administration (FDA) Committee voted to recommend the co-prescribing of naloxone with an opioid for patients at high risk of an overdose. The recommendation is consistent with the American Society of Anesthesiologists (ASA) position on this issue – a position formally conveyed to the FDA Committee last week. The decision […]
Read MoreOn January 2, 2019, the Association of periOperative Registered Nurses (AORN) opened a public comment period on revisions to its Guideline for Surgical Attire. The revised guideline includes a number of changes sought by the American Society of Anesthesiologists (ASA). ASA members are encouraged to read and provide their perspectives on the guideline through the public comment […]
Read More